期刊文献+

CD133^+CXCR4^+胃癌KATO-Ⅲ细胞的侵袭能力 被引量:1

High invasive capacity of CD133^+CXCR4^+ gastric cancer cells
下载PDF
导出
摘要 目的:研究CD133^+CXCR4^+胃癌细胞侵袭能力.方法:Transwell检测NCD133^-CXCR4^-、CD133^-CXCR4^+、CD133^+CXCR4^-、CD133^+CXCR4^+四组细胞迁移和侵袭能力.半定量酶链聚合反应检测CD133^+CXCR4^+组与CD133^+CXCR4^-组细胞上皮间质转化(epithelial mesenchymal transition,EMT1相关因子表达。分别用基质细胞衍生因子-1α(slromal cell derived factor-1α,SDF-1α)、AMD3100作用KATO-Ⅲ细胞后,Transwell检测CD133+ CXCR4^+组与CD133^+CXCR4^-组细胞侵袭能力,半定量酶链聚合反应检测KATO-Ⅲ细胞中EMT相关因子表达.结果:CD133^+CXCR4^+组平均迁移细胞数(136.67±14.36)高于CD133^+CXCR4^-组(55.33±7.37.P=0.01).CD133^+CXCR4^+组E-cadherin mRNA相对灰度值(0.3068±0.03991低于CD133^+CXCR4^-组(0.7665±0.0899,P=0.005).CD133^+CXCR4^+组N—Cadherin mRNA表达(0.5852±0.0453)、Snail mRNA表达(0.9178±0.0788)均高于CD133^+CXCR4^-组(0.2980±0.0626,P=0.006;0.6468±0.1506.P=0.03).CD133^+CxCR4^+组中,与对照组相比,SDF-1α组侵袭细胞数明显上升(P=0.033).SDF-1α组E-cadherin mRNA表达下降(P=0.018),而AMD3100组E-cadherin mRNA表达上升(P=0.008).SDF-1α SRSnail mRNA表达上升(P=0.028),而AMD3100组Snail mRNA表达下降(P=0.006).然而CD133^+CXCR4^-组中.SDF-1α组侵袭细胞数无明显变化.SDF-1α与AMD3100组E—cadherin mRNA与Snail mRNA表达均无明显变化.结论:CD133^+CXCR4^+胃癌细胞可能通过EMT和SDF-1α/CXCR4获得高侵袭能力. AIM: To assess the invasive capacity of CD133^+ CXCR4^+ gastric cancer cells. METHODS: The invasive and migration capacities of CD133^-CXCR4^-, CD133^-CXCR4^+, CD133^+CXCR4^-, and CD133^+CXCR4^+ gastric cancer ceils were assessed by Transwell assays. The mRNA expression of EMT related factors in CD133^+CXCR4^- and CD133^+CXCR4^+ cells was detected by semi-quantitative RT- PCR. After SDF-1α and AMD3100 were used to stimulate and inhibit KATO-Ⅲ cells, respectively, the invasive ability of CD133^+CXCR4^+ and CD133^+CXCR4^- cells was assessed, and themRNA expression of EMT related factors was detected by semi-quantitative RT-PCR. RESULTS: The mean number of migrated cells in the CD133^+CXCR4^- group was significantly more than that in the CD133^+CXCR4^- group (136.67± 14.36 vs 55.33 ± 7.37, P = 0.01). The expressive level of E-cadherin mRNA in the CD133^+CXCR4^+ group was significantly lower than that in the CD133^+CXCR4^- (0.3068 ± 0.0399 vs 0.7665 ± 0.0899, P = 0.005). The expressive levels of N-cadherin and Snail mRNAs in CD133^+CXCR4^+ cells were significantly stronger than those in CD133^+CXCR4^- cells (0.5852 ± 0.0453 vs 0.2980 ±0.0626, P = 0.006; 0.9178 ± 0.0788 vs 0.6468 ± 0.1506, P = 0.03). In CD133^+CXCR4^+ cells, SDF-1α treatment significantly increased the number of invasive cells (P = 0.033), decreased the expressive level of E-cadherin mRNA (P = 0.018), and increased the expressive level of Snail mRNA (P = 0.028). AMD3100 treatment significantly increased E-cadherin mRNA expression (P = 0.008) and decreased Snail mRNA expression (P = 0.006). In CD133^+CXCR4^- cells, SDF-1α or AMD3100 treatment did not significantly alter the invasion and expressive levels of E-cadherin and Snail mRNAs. CONCLUSION: The high invasion ability of CD133^+CXCR4^+ gastric cancer cells may be mediated by EMT and SDF-1α/CXCR4.
出处 《世界华人消化杂志》 CAS 北大核心 2014年第14期1977-1983,共7页 World Chinese Journal of Digestology
基金 蚌埠医学院研究生创新计划基金资助项目,No.Byycx1323 国家自然科学基金资助项目,No.81101850~~
关键词 胃癌 侵袭 CD133 SDF—1α细胞的侵袭能力细胞的侵袭能力 CXCR4 miR-18a HIF-1α Gastric cancer Proliferation
  • 相关文献

参考文献16

  • 1Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ. Cancer statistics, 2004. CA Cancer J Clin 2004; 54:8-29 [PMID: 14974761].
  • 2Scatena R, Bottoni P, PontoglJo A, Giardina B. Cancer stem cells: the development of new cancer therapeutics. Expert Opin Biol Ther 2011; 11:875-892 [PMID: 21463158 DOI: 10,1517/14712598].
  • 3O'Brien CA, Pollett A, Gallinger S, Dick JE. A hu- man colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106-110 [PMID: 17122772].
  • 4Rappa G, Fodstad O, Lorico A. The stem cell-asso- ciated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells 2008; 26:3008-3017 [PMID: 18802032 DOI: 10,1634/stemcells,2008-0601].
  • 5Hermann PC, Huber SL, Herrler T, Aicher A, Ell- wart JW, Guba M, Bruns CJ, Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancre- atic cancer. Cell Stem Cell 2007; 1:313-323 [PMID: 18371365 DOI: 10,1016/j.stem,2007.06.002].
  • 6Smith LM, Nesterova A, Ryan MC, Duniho S, Jonas M, Anderson M, Zabinski RF, Sutherland MK, Ger- ber HP, Van Orden KL, Moore PA, Ruben SM, Cart- er PJ. CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellu- lar and gastric cancers. Br ] Cancer 2008; 99:100-109 [PMID: 18542072 DOI: 10,1038/sj.bjc.6604437].
  • 7Sun X, Cheng G, Hao M, Zheng J, Zhou X, Zhang J, Taichman KS, Pienta KJ, Wang J. CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev 2010; 29:709-722 [PMID: 20839032 DOI: 10,1007/s10555-010-9256-x].
  • 8Zhang SS, Han ZP, Jing YY, Tao SF, Li TJ, Wang H, Wang Y, Li R, Yang Y, Zhao X, Xu XD, Yu ED, Rui YC, Liu HJ, Zhang L, Wei LX. CD133(+)CXCR4(+) co- lon cancer cells exhibit metastatic potential and pre- dict poor prognosis of patients. BMC IVied 2012; 10: 85 [PMID: 22871210 DOI: 10,1186/1741-7015-10-85].
  • 9姜海广,陆瑞祺,吴巨钢,周国才,俞继卫,姜波健.基质细胞源性因子-1α/CXC趋化因子受体-4轴经PI3K/Akt通路对胃癌细胞CD133表达的调控作用[J].中华实验外科杂志,2012,29(3):378-380. 被引量:13
  • 10Domanska UM, Timmer-Bosscha H, Nagengast WB, Oude Munnink TH, Kruizinga RC, Ananias HJ, Kliphuis NM, Huls G, De Vries EG, de Jong IJ, Walenkamp AM. CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemothera- py. Neoplasia 2012; 14:709-718 [PMID: 22952424].

二级参考文献28

共引文献35

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部